دورية أكاديمية
أعرض في EDS

Effect of prehospital high-dose glucocorticoid on hemodynamics in patients resuscitated from out-of-hospital cardiac arrest: a sub-study of the STEROHCA trial.

التفاصيل البيبلوغرافية
العنوان: Effect of prehospital high-dose glucocorticoid on hemodynamics in patients resuscitated from out-of-hospital cardiac arrest: a sub-study of the STEROHCA trial.
المؤلفون: Obling LER; Department of Cardiology, Rigshospitalet - Copenhagen University Hospital, Blegdamsvej 9, 2100, Copenhagen, OE, Denmark. laust.emil.roelsgaard.obling.01@regionh.dk., Beske RP; Department of Cardiology, Rigshospitalet - Copenhagen University Hospital, Blegdamsvej 9, 2100, Copenhagen, OE, Denmark., Meyer MAS; Department of Cardiology, Rigshospitalet - Copenhagen University Hospital, Blegdamsvej 9, 2100, Copenhagen, OE, Denmark., Grand J; Department of Cardiology, Rigshospitalet - Copenhagen University Hospital, Blegdamsvej 9, 2100, Copenhagen, OE, Denmark., Wiberg S; Department of Cardiology, Rigshospitalet - Copenhagen University Hospital, Blegdamsvej 9, 2100, Copenhagen, OE, Denmark.; Department of Thoracic Anesthesiology, Rigshospitalet - Copenhagen University Hospital, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Mohr T; Department of Intensive Care, Herlev-Gentofte Hospital - Copenhagen University Hospital, Copenhagen, Denmark., Damm-Hejmdal A; Copenhagen Emergency Services, Capital Region of Denmark, Copenhagen, Denmark., Forman JL; Department of Public Health, Section of Biostatistics, University of Copenhagen, Copenhagen, Denmark., Frikke-Schmidt R; Department of Clinical Biochemistry, Rigshospitalet - Copenhagen University Hospital, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Folke F; Copenhagen Emergency Services, Capital Region of Denmark, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.; Department of Cardiology, Herlev-Gentofte Hospital - Copenhagen University Hospital, Copenhagen, Denmark., Møller JE; Department of Cardiology, Rigshospitalet - Copenhagen University Hospital, Blegdamsvej 9, 2100, Copenhagen, OE, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.; Department of Cardiology, Odense University Hospital, Odense, Denmark., Kjaergaard J; Department of Cardiology, Rigshospitalet - Copenhagen University Hospital, Blegdamsvej 9, 2100, Copenhagen, OE, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Hassager C; Department of Cardiology, Rigshospitalet - Copenhagen University Hospital, Blegdamsvej 9, 2100, Copenhagen, OE, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
المصدر: Critical care (London, England) [Crit Care] 2024 Jan 22; Vol. 28 (1), pp. 28. Date of Electronic Publication: 2024 Jan 22.
نوع المنشور: Randomized Controlled Trial; Clinical Trial, Phase II; Journal Article
اللغة: English
بيانات الدورية: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 9801902 Publication Model: Electronic Cited Medium: Internet ISSN: 1466-609X (Electronic) Linking ISSN: 13648535 NLM ISO Abbreviation: Crit Care Subsets: MEDLINE
أسماء مطبوعة: Publication: London, UK : BioMed Central Ltd
Original Publication: London : Current Science Ltd, c1997-
مواضيع طبية MeSH: Out-of-Hospital Cardiac Arrest*/complications , Out-of-Hospital Cardiac Arrest*/drug therapy , Emergency Medical Services*, Humans ; Glucocorticoids/pharmacology ; Glucocorticoids/therapeutic use ; Coma/drug therapy ; Hemodynamics ; Norepinephrine/therapeutic use
مستخلص: Background: Following resuscitated out-of-hospital cardiac arrest (OHCA), inflammatory markers are significantly elevated and associated with hemodynamic instability and organ dysfunction. Vasopressor support is recommended to maintain a mean arterial pressure (MAP) above 65 mmHg. Glucocorticoids have anti-inflammatory effects and may lower the need for vasopressors. This study aimed to assess the hemodynamic effects of prehospital high-dose glucocorticoid treatment in resuscitated comatose OHCA patients.
Methods: The STEROHCA trial was a randomized, placebo-controlled, phase 2 trial comparing one prehospital injection of methylprednisolone 250 mg with placebo immediately after resuscitated OHCA. In this sub-study, we included patients who remained comatose at admission and survived until intensive care unit (ICU) admission. The primary outcome was cumulated norepinephrine use from ICU admission until 48 h reported as mcg/kg/min. Secondary outcomes included hemodynamic status characterized by MAP, heart rate, vasoactive-inotropic score (VIS), and the VIS/MAP-ratio as well as cardiac function assessed by pulmonary artery catheter measurements. Linear mixed-model analyses were performed to evaluate mean differences between treatment groups at all follow-up times.
Results: A total of 114 comatose OHCA patients were included (glucocorticoid: n = 56, placebo: n = 58) in the sub-study. There were no differences in outcomes at ICU admission. From the time of ICU admission up to 48 h post-admission, patients in the glucocorticoid group cumulated a lower norepinephrine use (mean difference - 0.04 mcg/kg/min, 95% CI - 0.07 to - 0.01, p = 0.02). Moreover, after 12-24 h post-admission, the glucocorticoid group demonstrated a higher MAP with mean differences ranging from 6 to 7 mmHg (95% CIs from 1 to 12), a lower VIS (mean differences from - 4.2 to - 3.8, 95% CIs from - 8.1 to 0.3), and a lower VIS/MAP ratio (mean differences from - 0.10 to - 0.07, 95% CIs from - 0.16 to - 0.01), while there were no major differences in heart rate (mean differences from - 4 to - 3, 95% CIs from - 11 to 3). These treatment differences between groups were also present 30-48 h post-admission but to a smaller extent and with increased statistical uncertainty. No differences were found in pulmonary artery catheter measurements between groups.
Conclusions: Prehospital treatment with high-dose glucocorticoid was associated with reduced norepinephrine use in resuscitated OHCA patients.
Trial Registration: EudraCT number: 2020-000855-11; submitted March 30, 2020. URL: https://www.
Clinicaltrials: gov ; Unique Identifier: NCT04624776.
(© 2024. The Author(s).)
References: Intensive Care Med. 2021 Apr;47(4):369-421. (PMID: 33765189)
J Am Heart Assoc. 2021 May 18;10(10):e019837. (PMID: 33960200)
Resuscitation. 2008 Feb;76(2):221-5. (PMID: 17875353)
Resuscitation. 2008 Dec;79(3):410-6. (PMID: 18990478)
Resuscitation. 2017 Dec;121:A12-A14. (PMID: 29055751)
Resuscitation. 2016 Aug;105:188-95. (PMID: 27321577)
World J Crit Care Med. 2012 Feb 04;1(1):4-9. (PMID: 24701395)
Resuscitation. 2023 Oct;191:109922. (PMID: 37543161)
Eur Heart J. 2024 Jan 7;45(2):89-103. (PMID: 37587550)
N Engl J Med. 2010 Mar 4;362(9):779-89. (PMID: 20200382)
Open Heart. 2022 Jan;9(1):. (PMID: 35046124)
Circulation. 2002 Jul 30;106(5):562-8. (PMID: 12147537)
Intensive Care Med. 2023 Dec;49(12):1467-1478. (PMID: 37943300)
Circulation. 2008 Dec 2;118(23):2452-83. (PMID: 18948368)
Acta Anaesthesiol Scand. 2023 Oct;67(9):1273-1287. (PMID: 37337696)
Intensive Care Med. 2013 Nov;39(11):1981-8. (PMID: 23995983)
Resuscitation. 2014 May;85(5):664-70. (PMID: 24412644)
Crit Care Med. 2005 Nov;33(11):2457-64. (PMID: 16276166)
Pediatr Crit Care Med. 2010 Mar;11(2):234-8. (PMID: 19794327)
Biomed Res Int. 2015;2015:314796. (PMID: 26421284)
Crit Care. 2023 Jan 11;27(1):12. (PMID: 36631807)
N Engl J Med. 2018 Mar 01;378(9):797-808. (PMID: 29347874)
Intensive Care Med. 2013 Nov;39(11):1972-80. (PMID: 23942856)
Resuscitation. 2023 Mar;184:109676. (PMID: 36572373)
Resusc Plus. 2022 May 26;10:100252. (PMID: 35652112)
Front Cardiovasc Med. 2022 Jul 07;9:894004. (PMID: 35872886)
J Neurosurg Anesthesiol. 2023 Jul 1;35(3):260-264. (PMID: 37192474)
Crit Care. 2018 Feb 27;22(1):52. (PMID: 29486781)
Resuscitation. 2021 Apr;161:61-79. (PMID: 33773833)
Trials. 2022 Nov 22;23(1):952. (PMID: 36414975)
Front Immunol. 2021 Aug 16;12:709155. (PMID: 34484209)
Resuscitation. 2022 Jul;176:1-8. (PMID: 35490935)
Clin Exp Pharmacol Physiol. 2010 Mar;37(3):358-61. (PMID: 19793107)
معلومات مُعتمدة: E-22652-04 Research Foundation of Rigshospitalet; NNF20OC0064043 Novo Nordisk Fonden
فهرسة مساهمة: Keywords: Hemodynamics; Inflammation; Intensive cardiovascular care; Out-of-hospital cardiac arrest; Post-cardiac arrest syndrome; Prehospital intervention; Vasopressor
سلسلة جزيئية: ClinicalTrials.gov NCT04624776
المشرفين على المادة: 0 (Glucocorticoids)
X4W3ENH1CV (Norepinephrine)
تواريخ الأحداث: Date Created: 20240123 Date Completed: 20240124 Latest Revision: 20240404
رمز التحديث: 20240405
مُعرف محوري في PubMed: PMC10801994
DOI: 10.1186/s13054-024-04808-3
PMID: 38254130
قاعدة البيانات: MEDLINE
الوصف
تدمد:1466-609X
DOI:10.1186/s13054-024-04808-3